Toggle navigation
Home
Search
Services
Blog
Contact
About
Function of the Amino-Terminal Domain of T3 Receptors
Colin, Idesbald
Massachusetts General Hospital, Boston, MA, United States
Search grants from Idesbald Colin
Search grants from Massachusetts General Hospital
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilience
Single-Center Phase I Study to Determine the Optimal Biologic Dose of CC-401
Dyslipoproteinemia in Silent Myocardial Ischemia
Protein-Membrane Interactions in the Intestinal Mucosa
Preventive Pulmonary Academic Award
Recently added grants:
OSU as a Network Lead Academic Participating Site for the NCI NCTN
Yale Cancer Center NCTN LAPS
ITSC for Leukemia: Novel Molecular strategies for NCTN 'Individualized' Therapies
Implantable pre-metastatic niche to elucidate the impact of chemotherapy-induced metastatic relapse
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Fellowships (FIC) (F05)
Project #
1F05TW004734-01
Application #
3022420
Study Section
International and Cooperative Projects 1 Study Section (ICP)
Project Start
1992-09-30
Project End
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Related projects
NIH 1993
F05 TW
Function of the Amino-Terminal Domain of T3 Receptors
Colin, Idesbald / Northwestern University at Chicago
NIH 1992
F05 TW
Function of the Amino-Terminal Domain of T3 Receptors
Colin, Idesbald / Massachusetts General Hospital
Comments
Be the first to comment on Idesbald Colin's grant